Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00729131 · ClinicalTrials.gov registry record

Functional Implications of TNF

A clinical trial of Bronchitis, sponsored by National Institute of Environmental Health Sciences (NIEHS).

Completed
Registry status
10
Enrollment target
1
Study location

NCT00729131: Completed study of Bronchitis, sponsored by National Institute of Environmental Health Sciences (NIEHS).

NCT00729131 is a study of Bronchitis that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00729131, a study of Bronchitis, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).

COMPLETED
Registry status
10 participants
Enrollment target
1
Study location

Study Summary

The research plan proposes to develop translational studies in humans that will identify host susceptibility factors that confer vulnerability to the prototypal air pollutant, ozone. Ozone is a ubiquitous urban air pollutant and associated with increased emergency room visits, and co-associates with other air pollutants, to increase mortality in high risk groups (cardio-pulmonary disease) of the population.The results will have significant impact upon and aid in understanding mechanisms of pro-oxidant lung injury, airway hyperresponsiveness, and adverse health effects, that occur during and following exposure to inhalable airborne irritants.

Conditions Studied

Interventions

  • DRUG Etanercept inhibition of ozone-induced airway hyper-responsiveness.

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2008-08
Est. Completion 2012-02

What the finished NCT00729131 record still lists

NCT00729131 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.

The record links to 1 condition, with Bronchitis appearing as the primary indexed condition, and to 1 intervention - of which Etanercept inhibition of ozone-induced airway hyper-responsiveness. is the first listed.

NCT00729131 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT00729131 about?

NCT00729131 is a clinical study titled "Functional Implications of TNF". The research plan proposes to develop translational studies in humans that will identify host susceptibility factors that confer vulnerability to the prototypal air pollutant, ozone. Ozone is a ubiquitous urban air pollutant and associated with increased emergency room visits, and co-associates with...

What is the current status of trial NCT00729131?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2008-08. Estimated completion is 2012-02.

What conditions does trial NCT00729131 study?

This clinical trial studies the following conditions: Bronchitis.

What interventions are being tested in trial NCT00729131?

The interventions under investigation include: Etanercept inhibition of ozone-induced airway hyper-responsiveness. (DRUG).

Who is sponsoring clinical trial NCT00729131?

This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00729131 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bronchitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00729131, the US trial registry maintained by the National Library of Medicine. NCT00729131 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.